PharmaSynth develops and produces precursors for PET and SPECT imaging, following GMP guidelines to supply the growing need of molecules used in medical research and diagnosis in medical centers around the world.


The human body is a complex system with many undiscovered details that are still a challenge in the scientific world. The research has its goal to advance the understanding of human body functions and use these findings to prevent and treat diseases and disorders.
PharmaSynth has the vision to play a significant role on a market where the pharmaceuticals used in humans have more and more strict requirements. Therefore, we strive to be among the first ones to introduce scientific innovations into medical practice in the field of imaging.


Our actions are guided by a set of values that we respect and comply with. Our business behavior is followed by all employees and all others acting on behalf of PharmaSynth.